JWM
DFTX

Janiczek Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Janiczek Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$73 Hold
10
– – ﹤0.01% 1071
2024
Q1 		$94 Hold
10
– – ﹤0.01% 1072
2023
Q4 		$37 Hold
10
– – ﹤0.01% 1124
2023
Q3 		$32 Hold
10
– – ﹤0.01% 1051
2023
Q2 		$36 Hold
10
– – ﹤0.01% 984
2023
Q1 		$32 Hold
10
– – ﹤0.01% 995
2022
Q4 		$31 Hold
10
– – ﹤0.01% 1023
2022
Q3 		$0 Hold
10
– – ﹤0.01% 1019
2022
Q2 		$0 Hold
10
– – ﹤0.01% 1031
2022
Q1 		$0 Hold
10
– – ﹤0.01% 1039
2021
Q4 		$0 Hold
10
– – ﹤0.01% 1066
2021
Q3 		$0 Hold
10
– – ﹤0.01% 1011
2021
Q2 		$1K Buy
+10
New +$525 ﹤0.01% 859

Other funds holding DFTX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janiczek Wealth Management's DFTX Position: Q2 2024 in Review

Janiczek Wealth Management held its Definium Therapeutics (DFTX) position steady in Q2 2024 at 10 shares worth $73. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Janiczek Wealth Management first reported a position in DFTX in Q2 2021 and has held it in 13 quarters since. The position peaked at $1K in Q2 2021. 151 funds tracked by Wall St. Rank hold DFTX as of Q2 2024.

  • Janiczek Wealth Management held 10 shares of Definium Therapeutics worth $73 as of Q2 2024.
  • Janiczek Wealth Management left its Definium Therapeutics share count unchanged in Q2 2024.
  • Definium Therapeutics made up ﹤0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #1071 holding.
  • Janiczek Wealth Management first reported a position in Definium Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • Janiczek Wealth Management's Definium Therapeutics position peaked at $1K in Q2 2021.
  • 151 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.